(90 days)
Not Found
Not Found
No
The summary describes a passive silicone implant with no mention of AI/ML terms, image processing, or performance studies related to algorithmic analysis.
No
The device is described as an implant intended to augment or reconstruct chin deficiencies, which falls under cosmetic or reconstructive surgery, not directly for the treatment of a disease or medical condition in a therapeutic sense.
No
Explanation: The device is an implant for augmentation or reconstruction, not a tool for diagnosing conditions or diseases.
No
The device description explicitly states it is manufactured from medical grade solid silicone elastomer, indicating it is a physical implant, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, or tissue) to provide information about a person's health.
- Device Description: The Spectrum Designs Anterior Chin Implant is a physical implant made of silicone elastomer that is surgically placed in the body. It does not perform any tests on bodily samples.
- Intended Use: Its intended use is to augment or reconstruct chin deficiencies, which is a surgical procedure, not a diagnostic test.
The information provided clearly describes a surgically implanted device, not a device used for in vitro testing.
N/A
Intended Use / Indications for Use
The Spectrum Designs Anterior Chin Implant is intended to augment or reconstruct congenital or traumatic chin deficiencies.
Product codes
FWP
Device Description
The Spectrum Designs Anterior Chin Implant is manufactured from medical grade solid silicone elastomer which is implanted in a pocket created by the surgeon, either intraorally or extraorally, in the mandibular region of the facial skeleton. It is provided non-sterile and available in six sizes.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
mandibular region of the facial skeleton, chin
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
McGhan Medical Corp. Curvilinear Chin Implant, Implantech Associates Curvilinear Silicone Chin Implant
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.3550 Chin prosthesis.
(a)
Identification. A chin prosthesis is a silicone rubber solid device intended to be implanted to augment or reconstruct the chin.(b)
Classification. Class II.
0
11 980 446
MAY 6 1898
SUMMARY OF SAFETY AND EFFECTIVENESS
SPECTRUM DESIGNS ANTERIOR CHIN IMPLANT 510K SUMMARY
1. Submitter's Data
Spectrum Designs Inc. 5921 C. Matthews Street Goleta, CA 93117
Contact Person: Jim Dishman (805) 681-4899 Telephone: December 30, 1997 Date Prepared:
2. Device Name, Classification
Name: Spectrum Designs Anterior Chin Implant FDA Classification: Class II, Prosthesis, Chin, Internal, Classification Number 79FWP, 21 CFR 878.3550
3. Identification of Substantially Equivalent Devices
Spectrum Designs Meniscus Chin Implant McGhan Medical Corp. Curvilinear Chin Implant Implantech Associates Curvilinear Silicone Chin Implant
4. Device Description
The Spectrum Designs Anterior Chin Implant is manufactured from medical grade solid silicone elastomer which is implanted in a pocket created by the surgeon, either intraorally or extraorally, in the mandibular region of the facial skeleton. It is provided non-sterile and available in six sizes.
5. Indications for Use
The Spectrum Designs Anterior Chin Implant is a silicone facial implant, designed to augment or reconstruct congenital or traumatic chin deficiencies.
6. Contraindications for Use
Contraindications for routine aesthetic surgery include the presence of infection anywhere in the body and in particular, in the region in which the device will be implanted.
7. Warnings, Precautions
Possible complications include:
- Displacement of the implant may occur, especially from dissection of too large a ● pocket.
- � Errors in positioning the implant may result in patient dissatisfaction
- Tissue necrosis may result in extrusion of the implant. This can occur as a result . of such factors as the pocket created being too small, use of too large an implant, or when soft tissues are inadequate to maintain coverage over the prosthesis
- Resorption of the underlying bone may occur with use of the implant. .
- Fibrous tissue encapsulation can occur around any implant, with subsequent ◆ increased firmness, possible displacement, and/or pains.
- � Complications from this or any similar surgery may include infection, neural damage, hematoma, poor would healing, patient intolerance to foreign body implantation, and other similar complications.
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles a stylized bird or a series of human profiles facing right. The logo is rendered in black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
C 1698 MAY
Mr. Jim Dishman ·Spectrum Designs, Incorporated 5921-C Matthews Street Goleta, California 93117
K980444 Re : Bilateral Groove Chin Implant Trade Name: K980445 Concave Back Chin Implant Trade Name: K980446 Trade Name: Anterior Chin Implant Regulatory Class: II Product Code: FWP Dated: January 17, 1998 February 5, 1998 Received:
Dear Mr. Dishman:
We have reviewed your Section 510(k) notification of intent to market the devices referenced above and we have determined these devices are substantially equivalent (for the indications for use stated in the enclosures) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the devices, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual reqistration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your devices are classified (see above) into either class II (Special Controls) or class III (Premarket Approval), they may be subject to such additional controls. Existing major regulations affecting your devices can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ਰੋ substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory
2
Page 2 - Mr. Dishman
In addition, FDA may publish further announcements action. concerning your devices in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
This letter will allow you to begin marketing your devices as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your devices to legally marketed predicate devices results in a classification for your devices and thus, permits your devices to proceed to the market.
If you desire specific advice for your devices on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your devices, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten, Ph.D., M.
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosures
3
INDICATIONS FOR USE
Applicant: Spectrum Designs Inc.
980446 510(k) Number ( if known): _
Device Name: Spectrum Designs Anterior Chin Implant
Indications for Use:
The Spectrum Designs Anterior Chin Implant is intended to augment or reconstruct congenital or traumatic chin deficiencies.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED).
Concurrence of CDRH Office of Device Evaluation (ODE)
Prescription use
Per 21 CFR 801.109
or
Over-the counter
(Division Sign-Off)
of General Restorative Devices 1077 k) Number